Abdominal Aortic Aneurysm Market Size in the 7MM is anticipated to Increase During the Study Period, 2019-2032, estimates DelveInsight

The Abdominal Aortic Aneurysm market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Abdominal Aortic Aneurysm pipeline products will significantly revolutionize the Abdominal Aortic Aneurysm market dynamics"

The Abdominal Aortic Aneurysm market report provides current treatment practices, Abdominal Aortic Aneurysm emerging drugs, market share of individual therapies, and current and forecasted 7MM Abdominal Aortic Aneurysm market size from 2019 to 2032. The report also covers current Abdominal Aortic Aneurysm treatment market practices/algorithms and unmet medical needs to curate the best opportunities and assess the market's underlying potential.

Key Takeaways from the Abdominal Aortic Aneurysm Market Research Report
• The key driver for the surge in market size is the rise in number of Abdominal Aortic Aneurysm prevalent case in 7MM.
• According to the National Center for Chronic Disease Prevention and Health Promotion, Abdominal aortic aneurysms are more common in men.
• The leading companies working in the Abdominal Aortic Aneurysm market include TriVascular Inc., Endologix, Cordis Corporation, Carelon Research, Quintiles Inc., Lifetech Scientific (Shenzhen) Co. Ltd, Shape Memory Medical Inc., Bolton Medical, Boston Scientific Corporation, RSPR Pharma AB, ViTAA Medical Solutions, Philips Healthcare, Vascutek Ltd, Medtronic, AstraZeneca, Abbott Medical Devices, Nectero Medical Inc., and others.
• Promising Abdominal Aortic Aneurysm Pipeline Therapies in the various stages of development include IMPEDE-FX Embolization Plug, QUANTUM LP™ STENT GRAFT SYSTEM, Cordis AAA Bilateral Device, CRD007, Optilene® Mesh Elastic, Ticagrelor, PEVAR (ProGlide closure), AFX EVAR AAA Graft System, Aneufix ACP-T5, IQOS, Cigarette, and others.
• On February 2023, Endologix announced a study of Nellix System. The objective of this study is to assess the safety and effectiveness of the Endologix Nellix® System for the endovascular repair of infrarenal abdominal aortic aneurysms (AAA).
• On July 2023, Cordis Corporation announced a study of clinical trials for Endovascular abdominal aortic aneurysm repair. INSIGHT is a postmarket clinical follow-up study in the European Union. The purpose of the study is to continue to evaluate the safety and effectiveness/performance of INCRAFT in subjects with abdominal aortic aneurysms requiring endovascular repair in routine clinical practice. Approximately 150 subjects will be enrolled and followed through 5-years post procedure. Up to 25 sites in Europe may participate.

Discover more about therapies set to grab major Abdominal Aortic Aneurysm Market Share @ Abdominal Aortic Aneurysm Market Size- https://www.delveinsight.com/report-store/abdominal-aortic-aneurysm-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Abdominal Aortic Aneurysm Overview
Aneurysms that occur in the section of the aorta that runs through the abdomen (abdominal aorta) are called abdominal aortic aneurysms (Abdominal Aortic Aneurysm). The portion of the aorta that lies deep inside the abdomen, right in front of the spine, is called the abdominal aorta.

Abdominal Aortic Aneurysm Epidemiology Segmentation in the 7MM
• Total Abdominal Aortic Aneurysm Prevalent Population
• Abdominal Aortic Aneurysm Diagnosed Cases
• Abdominal Aortic Aneurysm Gender-Specific Prevalence
• Abdominal Aortic Aneurysm Treatable Cases

Download the report to understand which factors are driving Abdominal Aortic Aneurysm Epidemiology Trends @ Abdominal Aortic Aneurysm Epidemiological Insights- https://www.delveinsight.com/sample-request/abdominal-aortic-aneurysm-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Abdominal Aortic Aneurysm Market Insights
Cardiovascular disease is widely recognized as the leading cause of death, a lesser-known fact is that aortic aneurysm (AA) is the 15th leading cause of death over the age of 65 years in the US. The golden standard of the treatments in Abdominal Aortic Aneurysm are invasive interventions either with open surgical repair (OS) or endovascular aneurysm repair (EVAR).

Abdominal Aortic Aneurysm Treatment Market
The concept of medical treatment is to prevent abdominal aortic aneurysm from rupture and avoid surgical treatment by preventing aneurysm enlargement or even reducing aneurysm size. Matrix metalloproteinases (MMP) are structurally related metalloendopeptidases that can degrade the extracellular matrix, and is thought to play important roles in Abdominal Aortic Aneurysm. There are many proposed pharmacological treatments, including β-blockers, angiotensin-converting enzyme inhibitor (ACE inhibitors), angiotensin-receptor blocker (ARB), statins, macrolides and, doxycycline, and an inhibitor of the MMP. Specific treatment is based on the age, overall health, medical history, and extent of the disease, signs and symptoms, tolerance of specific medications, procedures, or therapies.

To know more about Abdominal Aortic Aneurysm Treatment options, visit @ Abdominal Aortic Aneurysm Drugs- https://www.delveinsight.com/sample-request/abdominal-aortic-aneurysm-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Abdominal Aortic Aneurysm Market Dynamics
The Abdominal Aortic Aneurysm market dynamics is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rise in the awareness of the disease, and incremental healthcare spending across the world. The current Abdominal Aortic Aneurysm pipeline is limited as only a few companies are working on Abdominal Aortic Aneurysm. It provides an opportunity for other companies to enter the market and grab a significant market share. A few companies are also involved in developing Medical devices for the Abdominal Aortic Aneurysm treatment.

Abdominal Aortic Aneurysm Market Emerging Therapy Assessment
The available therapeutics treatment options in Abdominal Aortic Aneurysm Landscape aim to reduce complications arising. Companies such as Merck Serono and AstraZeneca are involved in developing Abdominal Aortic Aneurysm therapies. Launch of Abdominal Aortic Aneurysm emerging therapies, such as Metformin Glucophage (Merck Serono) and Ticagrelor (AstraZeneca) is expected to impact the treatment scenario of AAA significantly. Expected launch of Merck Serono (Metformin Glucophage) and Ticagrelor (AstraZeneca)shall fuel the growth of the market during the forecast period (2019-2032).

Abdominal Aortic Aneurysm Marketed Devices
• AFX® Endovascular ABDOMINAL AORTIC ANEURYSM System: Endologix LLC
The AFX® Endovascular ABDOMINAL AORTIC ANEURYSM System is an endovascular graft system intended to treat patients with ABDOMINAL AORTIC ANEURYSM. The device has a unique design in which the metal frame is on the inside of the fabric. It integrates anatomical fixation with an advanced delivery system and graft material technology. AFX® uses a low profile, precise delivery system and proprietary stent graft material (DuraPly™ ePTFE Graft Material) and provides reliable and durable ABDOMINAL AORTIC ANEURYSM repair. The AFX®2 bifurcated endograft system provides confident control for improved accessibility every step of the way.

Abdominal Aortic Aneurysm Emerging Devices
• Abdominal Aortic Aneurysm Stent Graft System: Lifetech Scientific
The company's ABDOMINAL AORTIC ANEURYSM Stent Graft System is indicated to treat patients with an infrarenal ABDOMINAL AORTIC ANEURYSMs. On September 30, 2018, Lifetech Scientific initiated its trial to evaluate the safety and efficacy of the ABDOMINAL AORTIC ANEURYSM Stent Graft System for the infrarenal ABDOMINAL AORTIC ANEURYSMs.
Products detail in the report…
• Fenestrated Altura FEVAR Stent Graft: Lombard Medical
Endovascular treatment of aortic diseases has improved in recent years. Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR) is an almost new minimally invasive technique for repairing thoracoabdominal or complex ABDOMINAL AORTIC ANEURYSMs.

Learn more about the Abdominal Aortic Aneurysm Pipeline Therapies in clinical trials @ Abdominal Aortic Aneurysm Market Landscape- https://www.delveinsight.com/sample-request/abdominal-aortic-aneurysm-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Abdominal Aortic Aneurysm Market Report
• Coverage- 7MM
• Study Period- 2019-2032
• Abdominal Aortic Aneurysm Companies- TriVascular Inc.(NYSE: TRIV), Endologix (NYSE: ELGX), Cordis Corporation, Carelon Research, Quintiles Inc (NYSE: IQV)., Lifetech Scientific (Shenzhen) Co. Ltd, Shape Memory Medical Inc., Bolton Medical, Boston Scientific Corporation (NYSE: BSX), RSPR Pharma AB, ViTAA Medical Solutions, Philips Healthcare (NYSE: PHQ), Vascutek Ltd, Medtronic (NYSE: MDT), AstraZeneca (NYSE: AZN), Abbott Medical Devices (NYSE: ABT), Nectero Medical Inc., and others.
• Abdominal Aortic Aneurysm Pipeline Therapies- IMPEDE-FX Embolization Plug, QUANTUM LP™ STENT GRAFT SYSTEM, Cordis AAA Bilateral Device, CRD007, Optilene® Mesh Elastic, Ticagrelor, PEVAR (ProGlide closure), AFX EVAR AAA Graft System, Aneufix ACP-T5, IQOS, Cigarette, and others.
• Abdominal Aortic Aneurysm Market Dynamics: Abdominal Aortic Aneurysm Market Drivers and Barriers
• Abdominal Aortic Aneurysm Market Access and Reimbursement, Unmet Needs, Future Perspectives

Discover more about Abdominal Aortic Aneurysm Drugs in development @ Abdominal Aortic Aneurysm Ongoing Clinical Trials Analysis- https://www.delveinsight.com/sample-request/abdominal-aortic-aneurysm-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Abdominal Aortic Aneurysm Market Report Introduction
3. Abdominal Aortic Aneurysm Pharma Market Overview at a Glance
4. Abdominal Aortic Aneurysm Disease Background and Overview
5. Abdominal Aortic Aneurysm Treatment
6. Abdominal Aortic Aneurysm: Regulatory Framework
7. Abdominal Aortic Aneurysm: Reimbursement Scenario
8. Abdominal Aortic Aneurysms: Marketed Products
9. Abdominal Aortic Aneurysm: Emerging Devices
10. Abdominal Aortic Aneurysm Epidemiology and Patient Population Analysis- 7MM
11. Abdominal Aortic Aneurysm Pharma Market Analysis-7MM
12. Abdominal Aortic Aneurysm Unmet Needs
13. Abdominal Aortic Aneurysm Market Drivers
14. Abdominal Aortic Aneurysm Market Barriers
15. Abdominal Aortic Aneurysm SWOT Analysis
16. Appendix
17. DelveInsight Capabilities
18. Disclaimer
19. About DelveInsight

Important Published Links-

https://treadmill.mn.co/posts/45459156
https://chineseintheus.mn.co/posts/parkinsons-disease-market-size-outlook-and-forecast
https://wear.net/dennydones9/
https://productinn.mn.co/posts/parkinsons-disease-market-outlook-and-forecast-report-2032
https://justchatting.mn.co/posts/45460636
https://expressyourcurve.mn.co/posts/45460860
https://clinalleve.mn.co/posts/parkinsons-disease-market-size-outlook-and-forecast-2032
https://nhattao.com/members/user6331540.6331540/
https://seedly.sg/profile/denny-dones/
https://note.com/denny_dones/n/n489e5dd1ff1a
https://www.storeboard.com/JohnSmith-5965202
https://doodleordie.com/profile/dennydones99
https://macro.market/company/delveinsight-business-research
https://pantip.com/profile/7306022#topics
https://allmylinks.com/dennydonesusa
https://uconnect.ae/read-blog/4382
https://blacksnetwork.net/post/102497_herpetic-keratitis-is-a-condition-that-affects-the-eye-and-is-caused-by-the-herp.html
https://ekonty.com/-dennydones99
https://app.wedonthavetime.org/posts/03e285b9-e449-4c96-b257-8cb7a2b74243
https://www.weddingbee.com/members/dennydones99/
https://community.storytellingwithdata.com/members/me/gallery
https://participer.valdemarne.fr/profiles/denny_dones/activity
https://elderassociation.mn.co/posts/45117025
https://www.domestika.org/en/dennydones99
https://nxgen.mn.co/members/19995548
https://www.laclt.com/profile/ybhardwaj/profile
https://stemfemmes.mn.co/posts/emerging-trends-in-managing-hot-flashes-in-the-prostate-cancer-market
https://network-91053.mn.co/posts/45119865
https://autism-support.mn.co/posts/understanding-hot-flashes-in-prostate-cancer-market-size-and-outlook-2032
https://jasa-seo.mn.co/posts/45120226
https://lapp.unl.edu.ec/profiles/dennydones99/activity?locale=en
https://imarticus.org/skillenza/user/dennydones9
https://oppathingzz.mn.co/members/20019648
https://findaspring.org/members/dennydones9/
https://www.poeticous.com/yashveer-bhardwaj
https://git.disroot.org/dennydones9
https://kuula.co/profile/havensmith
https://artmight.com/user/profile/3082810
https://www.credly.com/users/denny-dones/badges
https://quantum-buoyancy.mn.co/posts/axillary-hyperhidrosis-market-size-and-outlook-delveinsight
https://freeline.mn.co/posts/45202136
https://3dwarehouse.sketchup.com/user/0e9f9584-794e-4467-ac59-79db9efbadd9/Denny-Dones
https://www.hackster.io/dennydones9
https://letterboxd.com/dennydones9/
https://ko-fi.com/dennydones9
https://wakelet.com/@DennyDones813
https://onedio.com/profil/dennydones9
https://www.lyrics.com/user/349564/dennydones9#google_vignette
https://hypothes.is/users/dennydones9
https://shivambhu-hut.mn.co/posts/exploring-the-axillary-hyperhidrosis-market-innovations-treatments-and-future-prospects
https://zumvu.com/dennydones9/
https://onlyfans.com/dennydones9
https://maker.wiznet.io/dennydones9
https://collab.sundance.org/people/Denny-Dones-1699939772
https://insurtechasia.mn.co/posts/45403575
https://meganto-lottery.mn.co/posts/45403650
https://ylimun.mn.co/posts/45403740
https://network-79379.mn.co/posts/45404061
https://acatpg.mn.co/posts/45404422
https://brooklynneo.mn.co/posts/45404495
https://ucat-bootcamp.mn.co/posts/45404540
https://coding-playground.mn.co/posts/45404600
https://living-word-network.mn.co/posts/45404653

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers and acquisitions.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.